Is this your brand? Sign in to claim ownership.
Sign in to claim this brandmedArtis Medizinprodukte und Forschung Aktiengesellschaft
US
Last updated May 27, 2026
What medArtis Medizinprodukte und Forschung Aktiengesellschaft makes
medArtis produces synthetic, non-antimicrobial bone matrix implants designed for bone regeneration and reconstruction. Their portfolio includes variations of a single product line, marketed under names such as Synthacer and Syntricer, tailored for orthopedic and maxillofacial applications.
The company’s devices are classified as Class II under FDA regulations and are listed in the FDA’s Unique Device Identifier (UDI) database. The manufacturer is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does medArtis Medizinprodukte und Forschung Aktiengesellschaft manufacture?
medArtis specializes in synthetic, non-antimicrobial bone matrix implants. These devices are designed to support bone regeneration and reconstruction, primarily used in orthopedic and maxillofacial procedures. The company’s portfolio consists of variations of a single product line, marketed under names like Synthacer and Syntricer, which are tailored for specific surgical applications.
Where is medArtis Medizinprodukte und Forschung Aktiengesellschaft based?
medArtis is headquartered in the United States. The company’s location in the US aligns with its regulatory focus on FDA compliance, as evidenced by its device classifications and listings.
Which regulatory registries or databases list medArtis’s devices?
medArtis’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices regulated by the FDA, ensuring traceability and compliance with U.S. medical device regulations.
How are medArtis’s bone matrix implants classified under FDA regulations?
medArtis’s bone matrix implants are classified as Class II devices under FDA regulations. This classification typically applies to devices that pose moderate risk and require special controls to ensure their safety and effectiveness, such as those used in bone regeneration and reconstruction.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 313163545
Catalogue (752)
Page 1 of 16| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Synthacer | T6N205TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6109TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6N206TMC-1 | FDA UDI | Class II | Active |
| Synthacer/Syntricer | T672G01-2-1 | FDA UDI | Class II | Active |
| Syntricer | T7N3MM10-1 | FDA UDI | Class II | Active |
| Syntricer | T7N1G03-1 | FDA UDI | Class II | Active |
| Syntricer | T7N212TMC-1 | FDA UDI | Class II | Active |
| Syntricer | T7304TMO-1 | FDA UDI | Class II | Active |
| Syntricer | T7N308TMO-1 | FDA UDI | Class II | Active |
| Synthacer/Syntricer | T672G02-5-1 | FDA UDI | Class II | Active |
| Syntricer | T71G02-2-1 | FDA UDI | Class II | Active |
| Syntricer | T71MM05-1 | FDA UDI | Class II | Active |
| Synthacer | T6N112TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T61G02-2-1 | FDA UDI | Class II | Active |
| Syntricer | T7206TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T62GR03-1 | FDA UDI | Class II | Active |
| Synthacer/Syntricer | T672CB0406-5-1 | FDA UDI | Class II | Active |
| Synthacer | T63GR03-1 | FDA UDI | Class II | Active |
| Syntricer | T7N214TMC-1 | FDA UDI | Class II | Active |
| Syntricer | T73GR02-1 | FDA UDI | Class II | Active |
| Syntricer | T7211TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T6314TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6N206TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T6N217TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T6309TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T6N114TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T63G01-15-1 | FDA UDI | Class II | Active |
| Synthacer | T6N2CB03-1 | FDA UDI | Class II | Active |
| Synthacer | T6209TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6N3CB04-1 | FDA UDI | Class II | Active |
| Syntricer | T7N309TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T62G03-10-1 | FDA UDI | Class II | Active |
| Syntricer | T7N210TMO-1 | FDA UDI | Class II | Active |
| Syntricer | T7101TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6N3K13-1 | FDA UDI | Class II | Active |
| Syntricer | T7N314TMO-1 | FDA UDI | Class II | Active |
| Syntricer | T71G03-20-1 | FDA UDI | Class II | Active |
| Synthacer | T6N103TMC-1 | FDA UDI | Class II | Active |
| Syntricer | T72GR03-1 | FDA UDI | Class II | Active |
| Synthacer | T62MM10-1 | FDA UDI | Class II | Active |
| Synthacer | T6N306TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T6N315TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6N310TMC-1 | FDA UDI | Class II | Active |
| Synthacer/Syntricer | T671CB15-3-1 | FDA UDI | Class II | Active |
| Syntricer | T72G03-30-1 | FDA UDI | Class II | Active |
| Synthacer | T63G01-30-1 | FDA UDI | Class II | Active |
| Syntricer | T71CB0406-1 | FDA UDI | Class II | Active |
| Synthacer | T6N113TMO-1 | FDA UDI | Class II | Active |
| Synthacer | T6311TMC-1 | FDA UDI | Class II | Active |
| Synthacer | T6N208TMC-1 | FDA UDI | Class II | Active |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.